dutogliptin
Sponsors
Phenomix, Forest Laboratories
Conditions
Diabetes Mellitus, Type 2Diabetes Mellitus, Type IIRenal ImpairmentType 2 DiabetesType 2 Diabetes Mellitus
Phase 2
Phase 3
Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
TerminatedNCT00850239
Start: 2009-05-31End: 2010-12-31Target: 700Updated: 2010-08-11
Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
TerminatedNCT00865592
Start: 2009-03-31End: 2011-03-31Target: 450Updated: 2010-08-11
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin
TerminatedNCT00947557
Start: 2009-07-31Updated: 2011-09-21
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
TerminatedNCT00958269
Start: 2009-08-31End: 2011-11-30Target: 360Updated: 2010-02-03
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
TerminatedNCT00970424
Start: 2009-08-31Updated: 2011-09-21
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
TerminatedNCT00998686
Start: 2009-11-30End: 2011-11-30Target: 650Updated: 2010-08-11
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
TerminatedNCT01089790
Start: 2010-03-31Updated: 2011-09-21